Regional Medical Director, Value and Access - West

About Stoke: Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine. Using Stoke’s proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke’s first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke’s initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke’s proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit Position Purpose: The Regional Medical Director, Value and Access is a senior, field-based Medical Affairs leader who develops and executes the regional medical value strategy and serves as a scientific and strategic partner to payers, pharmacy benefit managers (PBMs), integrated delivery networks (IDNs), accountable care organizations (ACOs), Medicaid stakeholders, health technology assessment (HTA) bodies, and other population-health decision-makers. The role leads unbiased scientific exchange, translates clinical, health-economic, and real-world ev